Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2011
11/22/2011US8063036 Benzamides and related inhibitors of factor Xa
11/22/2011US8063035 Triazolyl aminopyrimidine compounds
11/22/2011US8063033 Therapeutic beta-lactams
11/22/2011CA2509151C Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone
11/22/2011CA2233620C Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies as antiinflammatory agents
11/17/2011WO2011143430A1 Indazole inhibitors of kinase
11/17/2011WO2011143365A1 Nitrogen heterocyclic compounds useful as pde10 inhibitors
11/17/2011WO2011143150A1 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
11/17/2011WO2011143105A1 Bifunctional quinoline derivatives
11/17/2011WO2011141909A2 Lipoic acid and nitroxide derivatives and uses thereof
11/17/2011WO2011141180A1 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING β2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
11/17/2011WO2011140681A1 Acrylamide compounds and use thereof for inhibiting apoptosis
11/17/2011US20110281915 Thienodithiine Derivatives
11/17/2011US20110281910 Hepatitis C Virus Inhibitors
11/17/2011US20110281899 Methods of preventing and treating low bone mass diseases
11/17/2011US20110281878 INHIBITORS OF p38
11/17/2011US20110281875 Inhibitors of IAP
11/17/2011US20110281851 Biphenyl compounds useful as muscarinic receptor antagonists
11/17/2011US20110281847 Selective estrogen receptor modulators for the treatment of vasomotor symptoms
11/17/2011US20110281838 5-alkynyl-pyrimidines
11/17/2011US20110281836 Silent desensitizers of neuronal NACHR and methods of use thereof
11/17/2011US20110281805 Use of an ang-(1-7) receptor agonist in acute lung injury
11/17/2011US20110280867 Heterocyclic aspartyl protease inhibitors
11/17/2011CA2799154A1 Indazole inhibitors of kinase
11/17/2011CA2799099A1 New cyclohexylamine derivatives having .beta.2 adrenergic agonist and m3 muscarinic antagonist activities
11/17/2011CA2798697A1 Lipoic acid and nitroxide derivatives and uses thereof
11/17/2011CA2798490A1 Nitrogen heterocyclic compounds useful as pde10 inhibitors
11/16/2011EP2386555A1 New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
11/16/2011EP2386551A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
11/16/2011EP2386550A1 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
11/16/2011EP1506166B1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/16/2011CN1938291B Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
11/16/2011CN102245601A Polymorph II of an antifungal compound
11/16/2011CN102245600A Pyrrolone melanin concentrating hormone receptor-1 antagonists
11/16/2011CN102241673A Acrylamide compounds and medicinal uses thereof
11/16/2011CN102241665A 4-(4,5-dimethoxycarboxyl-1,3-dithiolane-2-yl)benzoyl-L-amino acid benzyl ester as well as synthesis method and applications thereof
11/16/2011CN102241654A Environmentally-friendly synthetic method of pyrimidine compound
11/16/2011CN102241615A Multifunctional chiral amine compound, preparation method and application thereof
11/16/2011CN101704813B 1'-thio-indigo red compound as well as application and preparation method thereof
11/16/2011CN101547919B New dihydropyrimidine compounds and their uses in manufactures of pharmaceutical medicaments for treatment and prevention against virosis
11/16/2011CN101212973B 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
11/15/2011US8058457 Star-shaped oligothiophene-arylene derivatives and organic thin film transistors using the same
11/15/2011US8058446 [5-(Pyridin-2-ylamino)-6-oxo-1,6-dihydro-pyridin-3-yl]-(3-amido)-benzene derivatives; anticarcinogenic, antiproliferative, antiallergen, and antiinflammatory agents; lymphoma, leukemia, autoimmune diseases; Bruton's tyrosine kinase inhibitors
11/15/2011US8058445 Substituted pyridinecarboxamides for the treatment of cancer
11/15/2011US8058441 For control fertility, contraception, breast cancer, prostate cancer and endometriosis; modulating activity of the follicle stimulating hormone (FSH) receptor; 1-Acetyl-6-(tert-butoxycarbonyl)amino-4-phenyl-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline
11/15/2011US8058291 Methods and compositions for the treatment of CNS-related conditions
11/15/2011US8058284 [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto
11/15/2011US8058273 Histone deacetylases inhibitors
11/15/2011US8058271 Selective inhibitors of rock protein kinase and uses thereof
11/15/2011US8058245 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
11/15/2011CA2479126C Combination treatments for chemokine-mediated diseases
11/10/2011WO2011138916A1 Polycyclic compound
11/10/2011WO2011138666A1 Quinolylpiperazino substituted thiolactone compounds and process for the preparation thereof
11/10/2011WO2011138655A1 Aromatic monomers deriving from glycerol units, process for their preparation and use thereof for the preparation of water-soluble conjugated polymers
11/10/2011WO2011137487A1 Improved oligothiophenes
11/10/2011US20110275823 Phenylimidazole compounds
11/10/2011US20110275797 N-acyl anthranilic acid derivative or salt thereof
11/10/2011US20110275703 Substituted spiroketal derivatives and use thereof as therapeutic drug for diabetes
11/10/2011US20110275677 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity
11/10/2011US20110275669 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
11/10/2011US20110275608 Piperidine-containing compounds and use thereof
11/10/2011US20110272681 Light-emitting element material and light-emitting element
11/09/2011EP2385047A1 Piperidinyl-substituted isoquinolone derivatives
11/09/2011EP2385040A1 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
11/09/2011EP2385039A1 2-Iminoisoindolinone derivatives as thrombin receptor antagonists
11/09/2011EP2385038A1 Dimeric IAP inhibitors
11/09/2011EP2384753A1 Hydantoin derivatives as inhibitors of cellular necrosis
11/09/2011EP1899330B9 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect
11/09/2011EP1789390B1 Pyridyl inhibitors of hedgehog signalling
11/09/2011EP1651620B1 Piperazine derivatives and their use as therapeutic agents
11/09/2011EP1633740B1 5-(acylamino)indazole derivatives as kinase inhibitors
11/09/2011CN1882542B 2-pyridone derivatives as neutrophil elastase inhibitors and their use
11/09/2011CN102239165A Inhibitors of diacylglycerol acyltransferase
11/09/2011CN102239164A 2h-chromene compound and derivative thereof
11/09/2011CN102239160A Substituted (pyridyl)-azinylamine derivatives as fungicides
11/09/2011CN102239147A Quinolone compound and pharmaceutical composition
11/09/2011CN102238951A Pharmaceutical agent comprising quinolone compound
11/09/2011CN101405275B Triazolone derivative
11/09/2011CN101343251B Thrombopoietin mimetics
11/08/2011US8053450 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
11/08/2011US8053445 Utilities of olefin derivatives
11/08/2011US8053436 9-(piperazinylalkyl) carbazoles as bax-modulators
11/08/2011CA2493436C Indolinone derivatives, substituted in the 6-position, their preparation and their use as medicaments
11/08/2011CA2431675C Novel sulfamides and their use as endothelin receptor antagonists
11/08/2011CA2405408C Pyrazole compounds
11/03/2011WO2011137331A2 4-fluoro-4-arylpiperdin-1-yl derivatives as mu opioid function moderators
11/03/2011WO2011137072A1 Bicarbazole containing compounds for oleds
11/03/2011WO2011136520A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
11/03/2011WO2011136484A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
11/03/2011WO2011136269A1 Tetrahydrobenzothiophene compound
11/03/2011WO2011135376A1 Pyrazolyl quinazoline kinase inhibitors
11/03/2011WO2011135276A1 3, 3 -disubstituted- ( 8 - aza - bicyclo [3.2.1] oct- 8 - yl) -[5- (1h - pyrazol - 4 -yl) -thiophen-3 -yl] methanones as inhibitors of 11 (beta) -hsd1
11/03/2011WO2011134019A1 Novel biphenyl sartans
11/03/2011WO2010074747A8 Stable insecticide compositions and methods for producing same
11/03/2011WO2010052569A8 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
11/03/2011US20110269960 Triazole derivative
11/03/2011US20110269804 Insecticidal compounds
11/03/2011US20110269790 Novel thienopyridines as pharmacologically active agents
11/03/2011US20110269774 Pyrazolylaminopyridines as inhibitors of fak
11/03/2011US20110269768 Urotensin ii receptor antagonists
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 523